Trials / Completed
CompletedNCT00641680
Rhinocort Aqua Versus Placebo and Fluticasone Propionate
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-group, Phase IIIb Study to Assess the Efficacy, Safety & Product Attributes of Rhinocort Aqua(Budesonide) Versus Placebo and FluticasonePropionate as an Active Comparator in Patients 12yrs Age &Older With SeasonalAllergicRhinitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 750 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare once daily treatment with Rhinocort against placebo and Fluticasone Propionate at reliving the nasal symptoms of seasonal allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Budesonide | |
| DRUG | Fluticasone propionate | |
| DRUG | Placebo |
Timeline
- Start date
- 2003-04-01
- Primary completion
- 2003-07-01
- Completion
- 2003-07-01
- First posted
- 2008-03-24
- Last updated
- 2011-01-24
Source: ClinicalTrials.gov record NCT00641680. Inclusion in this directory is not an endorsement.